Literature DB >> 23817179

Spurious electrolyte disorders: a diagnostic challenge for clinicians.

George Liamis1, Evangelos Liberopoulos, Fotis Barkas, Moses Elisaf.   

Abstract

Spurious electrolyte disorders refer to an artifactually elevated or decreased serum electrolyte values that do not correspond to their actual systemic levels. When a clinician is confronted with a case of electrolyte disturbance, the first question should be whether it is an artifact. Spurious electrolyte disorders (pseudohyponatremia, pseudohypernatremia, pseudohypokalemia, pseudohyperkalemia, pseudohypomagnesemia, pseudohypophosphatemia, pseudohyperphosphatemia, pseudohypocalcemia and pseudohypercalcemia) are not infrequently observed in clinical practice. The recognition that an electrolyte disturbance may be an artifact may prevent inappropriate therapeutic interventions that could potentially have unfavorable outcomes. Clinicians must be alert to the possibility of spurious laboratory abnormalities when faced with conflicting laboratory values or measurements that are discordant with the clinical presentation. Moreover, in the presence of conditions that predispose to spurious electrolyte disorders, the normal measured electrolyte levels should raise the suspicion that true electrolyte disorders may be present.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23817179     DOI: 10.1159/000351804

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  14 in total

Review 1.  Drug-Induced Hypophosphatemia: Current Insights.

Authors:  Efstathia Megapanou; Matilda Florentin; Haralampos Milionis; Moses Elisaf; George Liamis
Journal:  Drug Saf       Date:  2020-03       Impact factor: 5.606

Review 2.  Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.

Authors:  G Liamis; T D Filippatos; A Liontos; M S Elisaf
Journal:  Hepatol Int       Date:  2016-06-21       Impact factor: 6.047

Review 3.  Diabetes mellitus and electrolyte disorders.

Authors:  George Liamis; Evangelos Liberopoulos; Fotios Barkas; Moses Elisaf
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

4.  Case-control study and case series of pseudohyperphosphatemia during exposure to liposomal amphotericin B.

Authors:  Nicole M Bohm; Katherine C Hoover; Amy E Wahlquist; Yusheng Zhu; Juan Carlos Q Velez
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191

Review 5.  Hyponatremia: pathophysiology, classification, manifestations and management.

Authors:  Helbert Rondon-Berrios; Emmanuel I Agaba; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2014-09-24       Impact factor: 2.370

6.  A Case of Hyperphosphatemia and Elevated Fibroblast Growth Factor 23: A Brief Review of Hyperphosphatemia and Fibroblast Growth Factor 23 Pathway.

Authors:  Joseph Wang; Beth Vogt; Sidharth Kumar Sethi; Matthew G Sampson; Virginia Vega-Warner; Edgar A Otto; Rupesh Raina
Journal:  Kidney Int Rep       Date:  2017-05-17

Review 7.  Hyponatremia in the elderly: challenges and solutions.

Authors:  Theodosios D Filippatos; Andromachi Makri; Moses S Elisaf; George Liamis
Journal:  Clin Interv Aging       Date:  2017-11-14       Impact factor: 4.458

8.  Initial Potassium Replacement in Diabetic Ketoacidosis: The Unnoticed Area of Gap.

Authors:  Atif Usman
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-21       Impact factor: 5.555

9.  Furosemide and spironolactone doses and hyponatremia in patients with heart failure.

Authors:  Ivan Velat; Željko Bušić; Marina Jurić Paić; Viktor Čulić
Journal:  BMC Pharmacol Toxicol       Date:  2020-08-03       Impact factor: 2.483

Review 10.  An overview of diagnosis and management of drug-induced hypomagnesemia.

Authors:  George Liamis; Ewout J Hoorn; Matilda Florentin; Haralampos Milionis
Journal:  Pharmacol Res Perspect       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.